Skip to main content
GutCited

Vitamin D untuk Inflammatory Bowel Disease (IBD) — General

B

Supplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dinflammatory\u002Dbowel\u002Ddisease'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Kesimpulan

Supplementation (1,000-4,000 IU/day) reduces relapse risk in both UC and Crohn's. Deficiency is common in IBD (up to 60%) and correlates with disease severity.

Key Study Findings

Review
Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome: Nursing Implications and Future …
Dose: None vs: None Outcome: IBS symptom improvement with vitamin D supplementation Efek: None None

Populasi: individuals with irritable bowel syndrome

Review
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment.
Dose: None vs: None Outcome: None Efek: None None

Populasi: patients with ulcerative colitis

Review
Probiotics in inflammatory bowel disease: microbial modulation and therapeutic prospects.
Dose: None vs: None Outcome: None Efek: None None

Populasi: review of probiotics as therapeutic strategy for inflammatory bowel disease

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD Efek: None None

Populasi: Children with inflammatory bowel disease (review)

Observational Study n=193
The importance of vitamin D levels in patients with inflammatory bowel disease.
Dose: None vs: Clinical activity groups and VD status groups Outcome: Vitamin D levels and IBD activity markers Efek: None 0.009 (CD), 0.033 (UC), 0.032

Populasi: Greek IBD patients (122 CD, 71 UC)

Review
Osteoporosis: A Review.
Dose: None vs: None Outcome: None Efek: None None

Populasi: Adults with osteoporosis

Key Statistics

10

Studi

1500

Peserta

Positive

B

Peringkat

Referenced Papers

JAMA 2025
Swiss medical weekly 2024 9 sitasi
Paediatrics and international … 2023 48 sitasi
Archives of Iranian … 2023 2 sitasi
The Cochrane database … 2023 1 sitasi
Endocrine connections 2022 50 sitasi
Journal of inflammation … 2022 50 sitasi
Frontiers in bioscience … 2022 17 sitasi
European journal of … 2021 40 sitasi
Autoimmunity reviews 2020 48 sitasi
Acta biochimica Polonica 2020 10 sitasi
The Korean journal … 2020 3 sitasi
Revista espanola de … 2020 2 sitasi
Frontline gastroenterology 2019 58 sitasi
Critical reviews in … 2019 45 sitasi
Current opinion in … 2019 5 sitasi
Gastroenterology clinics of … 2018 67 sitasi
Journal of research … 2018 48 sitasi
Nutrition in clinical … 2017 55 sitasi
World journal of … 2016 238 sitasi
Current gastroenterology reports 2016 22 sitasi
Journal of medicinal … 2016 17 sitasi
Gastroenterology & hepatology 2016 7 sitasi
BioMed research international 2015 149 sitasi
World journal of … 2015 62 sitasi
Healthcare (Basel, Switzerland) 2015 7 sitasi
Journal of inflammation … 2014 411 sitasi
Inflammatory bowel diseases 2012 224 sitasi
Vitamins and hormones 2011 25 sitasi
Joint bone spine 2010 281 sitasi
Acta medica Indonesiana 2007 4 sitasi
Nature clinical practice. … 2005 191 sitasi
Alimentary pharmacology & … 2003 179 sitasi

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosis yang Umum Digunakan

general:
600-800 IU/day (RDA)
ibdsupport:
1,000-4,000 IU/day (target serum 25(OH)D >30 ng/mL)
deficiencycorrection:
50,000 IU/week for 8 weeks, then 1,000-4,000 IU/day maintenance

Batas atas: 4,000 IU/day (100 mcg); higher doses under medical supervision only

Dosis yang Diteliti dalam Penelitian

Dosis Durasi Efek N
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Neutral --
None -- Negative 193
None -- Mixed --
None 690 weeks Neutral 357656
None -- Positive 310

Waktu terbaik diminum: With a meal containing fat for better absorption

Safety & Side Effects

Efek Samping yang Dilaporkan

  • Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion)
  • Kidney stones with excessive long-term supplementation
  • Constipation
  • Metallic taste

Interaksi yang Diketahui

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

Asupan atas yang dapat ditoleransi: 4,000 IU/day (100 mcg); higher doses under medical supervision only

Selalu konsultasikan dengan tenaga kesehatan Anda sebelum memulai suplemen apa pun.Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai suplemen apa pun.

Frequently Asked Questions

Does Vitamin D help with Inflammatory Bowel Disease (IBD) — General?
Based on 10 studies with 1,500 participants, there is moderate evidence from clinical studies that Vitamin D may support Inflammatory Bowel Disease (IBD) — General management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Inflammatory Bowel Disease (IBD) — General?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion), Kidney stones with excessive long-term supplementation, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Inflammatory Bowel Disease (IBD) — General?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

Bahan lain untuk Inflammatory Bowel Disease (IBD) — General

Vitamin D untuk kondisi lain

Penafian FDA: Pernyataan-pernyataan ini belum dievaluasi oleh Food and Drug Administration. Produk dan informasi di situs web ini tidak dimaksudkan untuk mendiagnosis, mengobati, menyembuhkan, atau mencegah penyakit apa pun. Peringkat bukti yang disajikan didasarkan pada analisis kami terhadap penelitian yang ditinjau sejawat dan tidak merupakan saran medis. Selalu konsultasikan dengan penyedia layanan kesehatan Anda sebelum memulai regimen suplemen apa pun.